14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 ZNTL stock ended at $11.71. This is 5.40% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.76% from a day low at $11.45 to a day high of $12.11.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Zentalis Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jan 17, 2024 $13.17 $13.46 $12.99 $13.45 723 039
Jan 16, 2024 $14.04 $14.04 $13.11 $13.38 652 426
Jan 12, 2024 $14.07 $14.68 $13.98 $14.26 817 300
Jan 11, 2024 $16.00 $16.00 $13.64 $13.88 1 493 752
Jan 10, 2024 $16.25 $16.83 $15.85 $15.98 585 991
Jan 09, 2024 $16.26 $16.46 $15.96 $16.38 373 961
Jan 08, 2024 $15.31 $16.51 $15.24 $16.49 745 120
Jan 05, 2024 $15.25 $15.45 $14.52 $15.39 515 240
Jan 04, 2024 $15.63 $15.91 $15.32 $15.44 497 365
Jan 03, 2024 $15.72 $16.12 $15.50 $15.60 806 439
Jan 02, 2024 $14.88 $16.29 $14.40 $15.99 858 330
Dec 29, 2023 $15.62 $15.71 $15.08 $15.15 479 185
Dec 28, 2023 $15.33 $16.53 $15.33 $15.58 738 273
Dec 27, 2023 $15.41 $15.83 $15.12 $15.32 501 043
Dec 26, 2023 $14.30 $15.53 $14.30 $15.32 818 751
Dec 22, 2023 $14.49 $15.04 $14.21 $14.41 932 646
Dec 21, 2023 $13.82 $14.44 $13.76 $14.30 612 241
Dec 20, 2023 $14.11 $14.75 $13.51 $13.56 1 838 248
Dec 19, 2023 $14.08 $14.71 $13.98 $14.25 1 012 664
Dec 18, 2023 $14.61 $14.78 $13.81 $13.88 808 717
Dec 15, 2023 $15.18 $15.26 $13.94 $14.67 3 451 525
Dec 14, 2023 $15.54 $15.55 $14.78 $14.96 1 094 144
Dec 13, 2023 $13.13 $15.46 $13.12 $15.17 1 565 127
Dec 12, 2023 $12.76 $12.95 $12.41 $12.82 873 347
Dec 11, 2023 $13.02 $13.41 $12.31 $12.80 1 460 287
Click to get the best stock tips daily for free!

About Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ... ZNTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT